Back to Search
MARK DEBRUIN, D.O.
D.O.
Family Medicine Physician
NPI: 1154327518IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
MIDWESTERN UNIVERSITY, CHICAGO COLLEGE OF OSTEOPATHIC MED
Class of 1988
Research & Publications (5)
A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy.
PMID 12774016·Hepatology·2003
3-trial
Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects.
PMID 12654665·Antimicrob Agents Chemother·2003
3-trial
A pilot trial of recombinant interleukin-12 in patients with chronic hepatitis C who previously failed treatment with interferon-alpha.
PMID 11513193·Am J Gastroenterol·2001
3-trial
Development of daptomycin for gram-positive infections.
PMID 11020247·J Antimicrob Chemother·2000
6-review
Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL.
PMID 10979901·J Infect Dis·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9352 MADISON AVE, STE. ONE
ORANGEVALE, CA 95662 - Phone
- (916) 989-2929
Quick Facts
- NPI
- 1154327518
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 5
Are you this provider?
Claim Your Profile